Dysautonomia Due to Reduced Cholinergic Neurotransmission Causes Cardiac Remodeling and Heart Failure

REFERENCES

• Amorim, D. S., H. J. Dargie, K. Heer, M. Brown, D. Jenner, E. G. Olsen, P. Richardson, and J. F. Goodwin. 1981. Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet i:525–527.
   Google Scholar
• Bartholomeu, J. B., A. S. Vanzelli, N. P. Rolim, J. C. Ferreira, L. R. Bechara, L. Y. Tanaka, K. T. Rosa, M. M. Alves, A. Medeiros, K. C. Mattos, M. A. Coelho, M. C. Irigoyen, E. M. Krieger, J. E. Krieger, C. E. Negrao, P. R. Ramires, S. Guatimosim, and P. C. Brum. 2008. Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J. Mol. Cell. Cardiol. 45:240–249.
   PubMedGoogle Scholar
• Bers, D. M. 2006. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21:380–387.
   PubMed Web of Science ®Google Scholar
• Bers, D. M. 2002. Cardiac excitation-contraction coupling. Nature 415:198–205.
   PubMed Web of Science ®Google Scholar
• Brandon, E. P., W. Lin, K. A. D'Amour, D. P. Pizzo, B. Dominguez, Y. Sugiura, S. Thode, C. P. Ko, L. J. Thal, F. H. Gage, and K. F. Lee. 2003. Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J. Neurosci. 23:539–549.
   PubMedGoogle Scholar
• Castro, C. H., R. A. Santos, A. J. Ferreira, M. Bader, N. Alenina, and A. P. Almeida. 2005. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46:937–942.
   PubMedGoogle Scholar
• Chakir, K., S. K. Daya, T. Aiba, R. S. Tunin, V. L. Dimaano, T. P. Abraham, K. M. Jaques-Robinson, E. W. Lai, K. Pacak, W. Z. Zhu, R. P. Xiao, G. F. Tomaselli, and D. A. Kass. 2009. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 119:1231–1240.
   PubMed Web of Science ®Google Scholar
• Cruz, J. S., and H. Matsuda. 1994. Depressive effects of arenobufagin on the delayed rectifier K+ current of guinea-pig cardiac myocytes. Eur. J. Pharmacol. 266:317–325.
   PubMedGoogle Scholar
• de Castro, B. M., X. De Jaeger, C. Martins-Silva, R. D. Lima, E. Amaral, C. Menezes, P. Lima, C. M. Neves, R. G. Pires, T. W. Gould, I. Welch, C. Kushmerick, C. Guatimosim, I. Izquierdo, M. Cammarota, R. J. Rylett, M. V. Gomez, M. G. Caron, R. W. Oppenheim, M. A. Prado, and V. F. Prado. 2009. The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol. Cell. Biol. 29:5238–5250.
   PubMedGoogle Scholar
• de Castro, B. M., G. S. Pereira, V. Magalhaes, J. I. Rossato, X. De Jaeger, C. Martins-Silva, B. Leles, P. Lima, M. V. Gomez, R. R. Gainetdinov, M. G. Caron, I. Izquierdo, M. Cammarota, V. F. Prado, and M. A. Prado. 2009. Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav. 8:23–35.
   PubMed Web of Science ®Google Scholar
• De Meersman, R. E., and P. K. Stein. 2007. Vagal modulation and aging. Biol. Psychol. 74:165–173.
   PubMed Web of Science ®Google Scholar
• Dhein, S., C. J. van Koppen, and O. E. Brodde. 2001. Muscarinic receptors in the mammalian heart. Pharmacol. Res. 44:161–182.
   PubMed Web of Science ®Google Scholar
• Duprez, D. A. 2008. Cardiac autonomic imbalance in pre-hypertension and in a family history of hypertension. J. Am. Coll. Cardiol. 51:1902–1903.
   PubMedGoogle Scholar
• Ferreira, A. J., T. L. Oliveira, M. C. Castro, A. P. Almeida, C. H. Castro, M. V. Caliari, E. Gava, G. T. Kitten, and R. A. Santos. 2007. Isoproterenol-induced impairment of heart function and remodeling are attenuated by the nonpeptide angiotensin-(1-7) analogue AVE 0991. Life Sci. 81:916–923.
   PubMed Web of Science ®Google Scholar
• Floras, J. S. 1993. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J. Am. Coll. Cardiol. 22:72A–84A.
   PubMed Web of Science ®Google Scholar
• Freeling, J., K. Wattier, C. LaCroix, and Y. F. Li. 2008. Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. Exp. Physiol. 93:75–82.
   PubMedGoogle Scholar
• Funakoshi, H., T. Kubota, N. Kawamura, Y. Machida, A. M. Feldman, H. Tsutsui, H. Shimokawa, and A. Takeshita. 2002. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ. Res. 90:959–965.
   PubMedGoogle Scholar
• Gehrmann, J., P. E. Hammer, C. T. Maguire, H. Wakimoto, J. K. Triedman, and C. I. Berul. 2000. Phenotypic screening for heart rate variability in the mouse. Am. J. Physiol. Heart Circ. Physiol. 279:H733–H740.
   PubMed Web of Science ®Google Scholar
• Grassi, G., G. Seravalle, F. Quarti-Trevano, and R. Dell'oro. 2009. Sympathetic activation in congestive heart failure: evidence, consequences and therapeutic implications. Curr. Vasc. Pharmacol. 7:137–145.
   PubMedGoogle Scholar
• Gros, R., X. You, L. L. Baggio, M. G. Kabir, A. M. Sadi, I. N. Mungrue, T. G. Parker, Q. Huang, D. J. Drucker, and M. Husain. 2003. Cardiac function in mice lacking the glucagon-like peptide-1 receptor. Endocrinology 144:2242–2252.
   PubMed Web of Science ®Google Scholar
• Guatimosim, S., E. A. Sobie, C. J. dos Santos, L. A. Martin, and W. J. Lederer. 2001. Molecular identification of a TTX-sensitive Ca(2+) current. Am. J. Physiol. Cell Physiol. 280:C1327–C1339.
   PubMed Web of Science ®Google Scholar
• Ishise, H., H. Asanoi, S. Ishizaka, S. Joho, T. Kameyama, K. Umeno, and H. Inoue. 1998. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J. Appl. Physiol. 84:1234–1241.
   PubMed Web of Science ®Google Scholar
• Kakinuma, Y., T. Akiyama, and T. Sato. 2009. Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium. FEBS J. 276:5111–5125.
   PubMedGoogle Scholar
• Kent, K. M., S. E. Epstein, T. Cooper, and D. M. Jacobowitz. 1974. Cholinergic innervation of the canine and human ventricular conducting system. Anatomic and electrophysiologic correlations. Circulation 50:948–955.
   PubMed Web of Science ®Google Scholar
• Korth, M., V. K. Sharma, and S. S. Sheu. 1988. Stimulation of muscarinic receptors raises free intracellular Ca2+ concentration in rat ventricular myocytes. Circ. Res. 62:1080–1087.
   PubMedGoogle Scholar
• LaCroix, C., J. Freeling, A. Giles, J. Wess, and Y. F. Li. 2008. Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am. J. Physiol. Heart Circ. Physiol. 294:H810–H820.
   PubMed Web of Science ®Google Scholar
• Lanzafame, A. A., A. Christopoulos, and F. Mitchelson. 2003. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors Channels 9:241–260.
   PubMedGoogle Scholar
• Li, M., C. Zheng, T. Sato, T. Kawada, M. Sugimachi, and K. Sunagawa. 2004. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109:120–124.
   PubMed Web of Science ®Google Scholar
• Lloyd-Mostyn, R. H., and P. J. Watkins. 1975. Defective innervation of heart in diabetic autonomic neuropathy. Br. Med. J. 3:15–17.
   PubMedGoogle Scholar
• Mabe, A. M., J. L. Hoard, M. M. Duffourc, and D. B. Hoover. 2006. Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene. Cell Tissue Res. 326:57–67.
   PubMedGoogle Scholar
• Martini, J. S., P. Raake, L. E. Vinge, B. DeGeorge, Jr., J. K. Chuprun, D. M. Harris, E. Gao, A. D. Eckhart, J. A. Pitcher, and W. J. Koch. 2008. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 105:12457–12462.
   PubMed Web of Science ®Google Scholar
• Misgeld, T., R. W. Burgess, R. M. Lewis, J. M. Cunningham, J. W. Lichtman, and J. R. Sanes. 2002. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 36:635–648.
   PubMed Web of Science ®Google Scholar
• Mungrue, I. N., R. Gros, X. You, A. Pirani, A. Azad, T. Csont, R. Schulz, J. Butany, D. J. Stewart, and M. Husain. 2002. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109:735–743.
   PubMed Web of Science ®Google Scholar
• Nagata, K., C. Ye, M. Jain, D. S. Milstone, R. Liao, and R. M. Mortensen. 2000. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes. Circ. Res. 87:903–909.
   PubMed Web of Science ®Google Scholar
• Okoshi, K., M. Nakayama, X. Yan, M. P. Okoshi, A. J. Schuldt, M. A. Marchionni, and B. H. Lorell. 2004. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion. Circulation 110:713–717.
   PubMedGoogle Scholar
• Oliveira, F. A., S. Guatimosim, C. H. Castro, D. T. Galan, S. Lauton-Santos, A. M. Ribeiro, A. P. Almeida, and J. S. Cruz. 2007. Abolition of reperfusion-induced arrhythmias in hearts from thiamine-deficient rats. Am. J. Physiol. Heart Circ. Physiol. 293:H394–H401.
   PubMedGoogle Scholar
• Olshansky, B., H. N. Sabbah, P. J. Hauptman, and W. S. Colucci. 2008. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118:863–871.
   PubMed Web of Science ®Google Scholar
• Pandya, K., H. S. Kim, and O. Smithies. 2006. Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc. Natl. Acad. Sci. U. S. A. 103:16864–16869.
   PubMed Web of Science ®Google Scholar
• Penela, P., C. Murga, C. Ribas, A. S. Tutor, S. Peregrin, and F. Mayor, Jr. 2006. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc. Res. 69:46–56.
   PubMed Web of Science ®Google Scholar
• Petrofski, J. A., and W. J. Koch. 2003. The beta-adrenergic receptor kinase in heart failure. J. Mol. Cell. Cardiol. 35:1167–1174.
   PubMed Web of Science ®Google Scholar
• Prado, V. F., C. Martins-Silva, B. M. de Castro, R. F. Lima, D. M. Barros, E. Amaral, A. J. Ramsey, T. D. Sotnikova, M. R. Ramirez, H. G. Kim, J. I. Rossato, J. Koenen, H. Quan, V. R. Cota, M. F. Moraes, M. V. Gomez, C. Guatimosim, W. C. Wetsel, C. Kushmerick, G. S. Pereira, R. R. Gainetdinov, I. Izquierdo, M. G. Caron, and M. A. Prado. 2006. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51:601–612.
   PubMed Web of Science ®Google Scholar
• Rota, M., T. Hosoda, A. De Angelis, M. L. Arcarese, G. Esposito, R. Rizzi, J. Tillmanns, D. Tugal, E. Musso, O. Rimoldi, C. Bearzi, K. Urbanek, P. Anversa, A. Leri, and J. Kajstura. 2007. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ. Res. 101:387–399.
   PubMedGoogle Scholar
• Serra, S. M., R. V. Costa, R. R. Teixeira De Castro, S. S. Xavier, and A. C. Nobrega. 2009. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J. Card. Fail. 15:124–129.
   PubMedGoogle Scholar
• Sharma, V. K., H. M. Colecraft, L. E. Rubin, and S. S. Sheu. 1997. Does mammalian heart contain only the M2 muscarinic receptor subtype? Life Sci. 60:1023–1029.
   PubMedGoogle Scholar
• Sharma, V. K., H. M. Colecraft, D. X. Wang, A. I. Levey, E. V. Grigorenko, H. H. Yeh, and S. S. Sheu. 1996. Molecular and functional identification of m1 muscarinic acetylcholine receptors in rat ventricular myocytes. Circ. Res. 79:86–93.
   PubMedGoogle Scholar
• Spragg, D. D., and D. A. Kass. 2006. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog. Cardiovasc. Dis. 49:26–41.
   PubMed Web of Science ®Google Scholar
• Thayer, J. F., and R. D. Lane. 2007. The role of vagal function in the risk for cardiovascular disease and mortality. Biol. Psychol. 74:224–242.
   PubMed Web of Science ®Google Scholar
• Vikstrom, K. L., T. Bohlmeyer, S. M. Factor, and L. A. Leinwand. 1998. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ. Res. 82:773–778.
   PubMedGoogle Scholar
• Wang, Z., H. Shi, and H. Wang. 2004. Functional M3 muscarinic acetylcholine receptors in mammalian hearts. Br. J. Pharmacol. 142:395–408.
   PubMed Web of Science ®Google Scholar
• Wu, J. S., F. H. Lu, Y. C. Yang, T. S. Lin, J. J. Chen, C. H. Wu, Y. H. Huang, and C. J. Chang. 2008. Epidemiological study on the effect of pre-hypertension and family history of hypertension on cardiac autonomic function. J. Am. Coll. Cardiol. 51:1896–1901.
   PubMed Web of Science ®Google Scholar
• Yang, L. L., R. Gros, M. G. Kabir, A. Sadi, A. I. Gotlieb, M. Husain, and D. J. Stewart. 2004. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 109:255–261.
   PubMed Web of Science ®Google Scholar